These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation. Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM J Biol Chem; 2012 Feb; 287(6):3642-58. PubMed ID: 22147710 [TBL] [Abstract][Full Text] [Related]
45. The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide. Guo XH Curr Med Res Opin; 2016; 32(1):61-76. PubMed ID: 26439329 [TBL] [Abstract][Full Text] [Related]
46. The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling. Dods RL; Donnelly D Biosci Rep; 2015 Nov; 36(1):e00285. PubMed ID: 26598711 [TBL] [Abstract][Full Text] [Related]
47. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice. Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410 [TBL] [Abstract][Full Text] [Related]
48. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors. Al-Sabah S; Donnelly D Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080 [TBL] [Abstract][Full Text] [Related]
49. Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation. Thompson A; Stephens JW; Bain SC; Kanamarlapudi V PLoS One; 2016; 11(4):e0154229. PubMed ID: 27100083 [TBL] [Abstract][Full Text] [Related]
50. The amino terminal domain of the glucagon-like peptide-1 receptor is a critical determinant of subtype specificity. Graziano MP; Hey PJ; Strader CD Recept Channels; 1996; 4(1):9-17. PubMed ID: 8723643 [TBL] [Abstract][Full Text] [Related]
51. Structure and Molecular Mechanism of Signaling for the Glucagon-like Peptide-1 Receptor Bound to Gs Protein and Exendin-P5 Biased Agonist. Li B; Maruszko K; Kim SK; Yang MY; Vo AP; Goddard WA J Am Chem Soc; 2023 Sep; 145(37):20422-20431. PubMed ID: 37672637 [TBL] [Abstract][Full Text] [Related]
53. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function. Koole C; Wootten D; Simms J; Savage EE; Miller LJ; Christopoulos A; Sexton PM J Biol Chem; 2012 Feb; 287(6):3659-73. PubMed ID: 22147709 [TBL] [Abstract][Full Text] [Related]
54. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor. Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966 [TBL] [Abstract][Full Text] [Related]
55. Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for Wang H; Hu W; Liu D; Wüthrich K FEBS J; 2021 Jul; 288(13):4053-4063. PubMed ID: 33369025 [TBL] [Abstract][Full Text] [Related]
56. Effects of Replacing a Central Glycine Residue in GLP-1 on Receptor Affinity and Signaling Profile. Brown KA; Gellman SH Chembiochem; 2023 Nov; 24(21):e202300504. PubMed ID: 37624685 [TBL] [Abstract][Full Text] [Related]
57. Activation of glucagon-like peptide-1 receptors reduces the acquisition of aggression-like behaviors in male mice. Vestlund J; Zhang Q; Shevchouk OT; Hovey D; Sebastian L; Westberg L; Jerlhag E Transl Psychiatry; 2022 Oct; 12(1):445. PubMed ID: 36229445 [TBL] [Abstract][Full Text] [Related]
58. Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors. Zhao F; Zhou Q; Cong Z; Hang K; Zou X; Zhang C; Chen Y; Dai A; Liang A; Ming Q; Wang M; Chen LN; Xu P; Chang R; Feng W; Xia T; Zhang Y; Wu B; Yang D; Zhao L; Xu HE; Wang MW Nat Commun; 2022 Feb; 13(1):1057. PubMed ID: 35217653 [TBL] [Abstract][Full Text] [Related]
59. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143 [TBL] [Abstract][Full Text] [Related]
60. Identification of N-Terminally Diversified GLP-1R Agonists Using Saturation Mutagenesis and Chemical Design. Longwell CK; Hanna S; Hartrampf N; Sperberg RAP; Huang PS; Pentelute BL; Cochran JR ACS Chem Biol; 2021 Jan; 16(1):58-66. PubMed ID: 33307682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]